Cell type- and transcription-independent spatial proximity between enhancers and promoters.


Journal

Molecular biology of the cell
ISSN: 1939-4586
Titre abrégé: Mol Biol Cell
Pays: United States
ID NLM: 9201390

Informations de publication

Date de publication:
08 May 2024
Historique:
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 8 5 2024
Statut: aheadofprint

Résumé

Cell type-specific enhancers are critically important for lineage specification. The mechanisms that determine cell type-specificity of enhancer activity, however, are not fully understood. Most current models for how enhancers function invoke physical proximity between enhancer elements and their target genes. Here, we use an imaging-based approach to examine the spatial relationship of cell type-specific enhancers and their target genes with single cell resolution. Using high-throughput microscopy, we measure the spatial distance from target promoters to their cell type-specific active and inactive enhancers in individual pancreatic cells derived from distinct lineages. We find increased proximity of all promoter-enhancer pairs relative to non-enhancer pairs separated by similar genomic distances. Strikingly, spatial proximity between enhancers and target genes was unrelated to tissue-specific enhancer activity. Furthermore, promoter-enhancer proximity did not correlate with the expression status of target genes. Our results suggest that promoter-enhancer pairs exist in a distinctive chromatin environment but that genome folding is not a universal driver of cell type-specificity in enhancer function.

Identifiants

pubmed: 38717453
doi: 10.1091/mbc.E24-02-0082
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

mbcE24020082

Auteurs

Yasmine Mian (Y)

National Cancer Institute, NIH, Bethesda, MD, 20892.

Li Wang (L)

National Cancer Institute, NIH, Bethesda, MD, 20892.

Adib Keikhosravi (A)

National Cancer Institute, NIH, Bethesda, MD, 20892.

Konnie Guo (K)

National Cancer Institute, NIH, Bethesda, MD, 20892.

Tom Misteli (T)

National Cancer Institute, NIH, Bethesda, MD, 20892.

H Efsun Arda (HE)

National Cancer Institute, NIH, Bethesda, MD, 20892.

Elizabeth H Finn (EH)

National Cancer Institute, NIH, Bethesda, MD, 20892.
Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104.

Classifications MeSH